Merete Lund Hetland

Merete Lund Hetland

Clinical Professor

Member of:

  • Internal Medicine: Rheumatology


Publication year:
All
451 - 454 out of 454Page size: 10
  1. 2005
  2. Published

    DANBIO: a nationwide registry of biological therapies in Denmark

    Hetland, Merete Lund, 2005, In: Clinical and Experimental Rheumatology. 23, Suppl 39, p. 205-7

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Prescription practice of biological drugs in rheumatoid arthritis during the first three years of postmarketing use in Denmark and Norway: criteria are becoming less stringent.

    Hjardem, E., Hetland, M., Østergaard, Mikkel, Krogh, N. S., Kvien, T. K. & Hetland, Merete Lund, 2005, In: Annals of the Rheumatic Diseases. 64, 8, p. 1220-3

    Research output: Contribution to journal › Journal article › Research

  4. Published

    Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)

    Hetland, M., Unkerskov, J., Ravn, T., Friis, M., Tarp, U., Andersen, L. S., Petri, A., Khan, H., Stenver, D., Hansen, A., Østergaard, Mikkel & Hetland, Merete Lund, 2005, In: Scandinavian Journal of Rheumatology. 34, 1, p. 40-4

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2004
  6. Published

    Serum VEGF increases in RA patients prior to relapse after withdrawal of DMARD.

    Hetland, M., Hansen, M. S., Stoltenberg, M., Gøtzsche, P., Østergaard, Mikkel & Hetland, Merete Lund, 2004. 0 p.

    Research output: Contribution to conference › Poster › Research

Previous 1...42 43 44 45 46 Next

ID: 922207